Unlike earlier GLP-1 receptor agonists, retatrutide is a triple agonist : GLP-1 receptor agonist suppresses appetite, slows gastric emptying, improves insulin sensitivity GIP receptor agonist enhances insulin release, amplifies GLP-1 effects Glucagon receptor agonist stimulates energy expenditure, fat metabolism, and potentially impacts lipid handling Clinical trials so far have shown remarkable weight loss (up to 24% in some studies) and strong metabolic improvements, including effects on lipids like LDL cholesterol
(3) Johnson B, Milstead M, Thomas O, McGlasson T, Green L, Kreider R and Jones R (2025) Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study
Although a recent clinical trial failed to show significant benefit, Scott Kanoski, PhD, professor of biological sciences at University of Southern California, cautions against closing the door on this area
Mana, Kellie E
One of their areas of investigation was the type and duration of side effects between the two groups
News about Prescription Drug Affordability Boards (PDABs) Maryland's and Colorado's PDAB stakeholder councils met on April 28 and April 24, 2025
